TRANSPLANT DIAGNOSTICS MARKET SIZE TO CROSS USD 1.7 BILLION BY 2025, GROWING AT A CAGR OF 6% DURING THE FORECAST PERIOD

Transplant Diagnostics Market Size, Share, & Trends Analysis Report by Product (Instruments & Software and Consumables & Test Kits), Application (Diagnostic and Research), Technology (Molecular and Non-Molecular), Transplantation Type (Solid Organ and Soft Tissue), End-Users (Standard Reference Laboratories, Hospitals & Transplant Centers, and Research & Academic Institutes), and Geography (Europe, North America, APAC, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

284 Pages

icon-table

37 Tables

icon-chart

178 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

14 Companies

icon-market

6 Market Segment

TRANSPLANT DIAGNOSTICS MARKET REPORT SCOPE

Report Attribute Details
Market Size (REVENUE) USD 1.7 BILLION (2025)
CAGR 6% (2020 - 2025)
Base Year 2019
Forecast Year 2020-2025
Market Segments Product (Instruments & Software and Consumables & Test Kits), Application (Diagnostic and Research), Technology (Molecular and Non-Molecular), Transplantation Type (Solid Organ and Soft Tissue), End-Users (Standard Reference Laboratories, Hospitals & Transplant Centers, and Research & Academic Institutes)
Geographic Analysis Europe, North America, APAC, Latin America, and Middle East & Africa
Countries Covered Spain, France, Germany, UK, Italy, Canada, US, China, Japan, South Korea, India, Australia, Brazil, Argentina, Mexico, Saudi Arabia, Iran, South Africa, and Israel

INDUSTRY INSIGHTS 

The transplant diagnostics market size to cross USD 1.7 billion by 2025, growing at a CAGR of 6% during the forecast period. The global transplant diagnostics market is growing at a steady rate, which is expected to continue during the forecast period. The high demand for molecular diagnostic tests and the availability of technologically advanced devices with favorable patient demographics are mainly contributing to the high demand for transplant diagnostics devices. Ongoing technological advancements and innovations witnessed in the development of new genomic, transcriptomic, and proteomic biomarkers, especially in the molecular segment, can provide personalized management for transplantation and can detect rejection episodes and infections early, thereby improving the patient outcomes and success rate.

SNIPPETS

  • APAC is likely to witness the highest absolute growth, whereas North America is expected to observe the highest incremental growth during the forecast period.
  • Technological innovations are making devices more convenient and laced with advanced features.
  • The adoption of molecular and non-molecular diagnostics techniques is increasing in popularity worldwide.
  • The rapidly growing chronic diseases is a crucial factor fueling the demand for solid organ transplantation as well as stem cell transplantation.
  • The diagnostics applications segment is growing at a healthy rate. The segment is expected to observe an incremental growth of over $376 million during the forecast period.

TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION 

This research report includes detailed segmentation by

  • Product
  • Application
  • Technology
  • Transplantation type
  • End-user
  • Geography

INSIGHTS BY PRODUCTS 

The increasing usage of a wide array of reagents and test kits to perform transplant diagnostics tests is a significant factor affecting the growth of the reagents & consumables product segment. The segment is growing at a faster rate than the instruments & software product segment due to their recurring purchase by end-users for performing molecular and non-molecular transplant tests.

The instruments and software segment is growing due to the rise in organ and tissue transplantations and the adoption of advanced techniques. The segment is growing at a relatively slow pace than the consumables & test kits segment as it is capital intensive, and purchasing decisions for these equipment depend on financial resources and budget allocations.

INSIGHTS BY APPLICATIONS 

The research application segment is likely to witness faster growth than the clinical application segment as the number of research activities and clinical trials related to transplantation, especially stem cells, is increasing worldwide. The increase in the number of clinical trials and ongoing research activities to improve clinical outcomes is encouraging end-users to effectively screen donors and recipients, perform compatibility assessments and diagnose complications such as organ rejection and infections using molecular and non-molecular tests.

The diagnostics applications segment is growing at a healthy rate and is expected to grow during the forecast period. Transplantation is the treatment of choice for several patients with end-stage organ failure diseases. Significant signs of progress have been achieved both in short-term outcomes and long-term graft survival due to the increasing availability of molecular and serological-based tests to monitor transplant patients. Hence, technological improvements have further increased the application of the segment.

INSIGHTS BY TECHNOLOGY  

The growing number of solid organ and stem cell replacement, advances in organ transplantation, increase in funding and research grants, and improved public-private investments, and the shift from serological-based tests to gene-based HLA profiling are major factors contributing the growth of the segment. The segment is growing at a faster rate with a CAGR of 8% during the forecast period. The growing adoption of molecular-based techniques in transplantations with the wide availability of PCR and sequence-based products is contributing to the growth of the segment.

In 2019, the non-molecular technology segment accounted for a 38% share of the global transplant diagnostics market. Non-molecular tests have also been contributing sizeable revenues to the global transplant diagnostics market. Several vendors are offering non-molecular testing products, which is further contributing to the growth.

INSIGHTS BY TRANSPLANTATION TYPE   

The solid organ transplantation market segment accounted for a 58% share of the global transplant diagnostics market. Solid-organ transplantation has become vital in treating patients suffering from terminal illnesses. Therefore, the global number of solid organ transplantations is increasing at a healthy rate despite interruptions in the organ donation supply mechanism. Incidences of end-stage organ failures are high among patients with chronic diseases, thereby increasing the need for solid organ transplantations. The growth in hematological cancer cases is a key factor for the increasing demand for stem cell therapy worldwide. 

INSIGHTS BY END-USER 

Standard reference laboratories conduct tests to identify donor receiver compatibility pre-transplantation. As the number of organs, cells, and tissue replacements is growing worldwide, the demand for laboratory testing is likely to rise at a steady rate. Government financial support for these laboratories is another major factor for the growth of the segment.

Hospitals & transplant centers accounted for a 37% share of the global transplant diagnostics market in 2019. Healthcare professionals in hospitals and transplant centers use various instruments, accessories, and software for conducting pre and post-transplantation diagnostics tests. The market is growing at a healthy rate due to the adoption of advanced instruments accessories and software for organs, cells, and tissue transplantations. The availability of skilled healthcare professionals to perform diagnostics tests also attracts more patients to hospitals and transplant centers. Also, favorable reimbursement for transplant diagnostics is another factor boosting the end-user segment.

INSIGHTS BY GEOGRAPHY 

North America is the major revenue contributor to the global transplant diagnostics market followed by Europe, APAC, Latin America, and MEA. The region contributed a share of 42% in the year 2019. North America is considered as an attractive market for transplant diagnostics due to high healthcare expenditure in the region.

The transplant diagnostics market in Europe is the second-largest market and accounted for 31% share of the global market. France, the UK, Spain, Germany, and Italy are the major revenue contributors to the Europe market. The APAC region has the largest population density and the highest proportion of various chronic diseases. China is the major revenue contributor in APAC.

Brazil, Mexico, and Argentina are the major revenue contributors to the market in Latin America. The market in Brazil is driven by the increasing chronic disease population, which is leading to the demand for advanced medical treatment options for organ and tissue transplantations. However, the Latin American market is confronted with the unique challenge of infectious disease diagnostics. MEA accounts for the lowest share of the market. The small share can be attributed to poor deceased-donor transplantations in several MEA countries. 

INSIGHTS BY VENDORS

The global transplant diagnostics market is moderately competitive and characterized by the presence of a few players offering these products. It is consolidated with a few players accounting for around 75% of the overall market in 2019. The market is witnessing rapid technological advancements, especially in the molecular diagnostics segment. Moreover, key players are witnessing increased competition from various regional and local players globally. 

The transplant diagnostics market research report includes industry analysis with revenue and forecast insights for the following segments: 

Segmentation by Product 

  • Instruments & Software
  • Consumables & Test Kits

By End-user  

  • Standards Reference Laboratories
  • Hospitals and Transplant Centers
  • Research and Academic Centers

By Transplant Type 

  • Solid Organs
  • Soft Tissues

By Technology   

  • Molecular
  • Non-molecular

By Application

  • Diagnostic
  • Research

By Geography

  • Europe
    • Spain
    • France
    • Germany
    • UK
    • Italy
  • North America
    • Canada
    • US
  • APAC
    • China
    • Japan
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • Iran
    • South Africa
    • Israel

Frequently Asked Questions

What is the market size and compound annual growth rate of the transplant diagnostics market?

The transplant diagnostics market size is expected to reach revenues of $1.7 billion, growing at a CAGR of 6% during 2019-2025.

What are the factors influencing the growth of the hospitals and transplant centers segment during the forecast period?

The availability of skilled healthcare professionals to perform diagnostics tests also attracts more patients to hospitals and transplant centers.

What is the growth of the molecular and non-molecular segment market shares by 2025?

In 2019, the non-molecular technology segment accounted for a 38% share of the global transplant diagnostics market.

Who are the major key players in the transplant diagnostics market and what are their market shares?

The key players in the transplant diagnostics market are Thermo Fisher Scientific, Hoffmann-La Roche, bioMérieux, Bio-Rad Laboratories, QIAGEN, and Immucor. It is consolidated with a few players accounting for around 75% of the overall market in 2019.

How is the growing population in the Asia Pacific region impacting the growth of transplant diagnostics market?

The APAC region has the largest population density and the highest proportion of various chronic diseases. China is the major revenue contributor in APAC.

Download Free Sample

The global transplant diagnostics market is expected to grow at a CAGR of over 6% during the forecast period 2019–2025.

 The following factors are likely to contribute to the growth of the transplant diagnostics market during the forecast period:

  • Growing Number of Transplantations & Prevalence of Chronic Diseases
  • Increasing Shift from Serological to Molecular Diagnostic Testing in Transplant Patients
  • Emergence of cfDNA in Transplant Diagnostics
  • Increasing Focus on Identifying New Biomarkers for Minimizing Transplantation Rejection

 Base Year:                  2019

Forecast Year:           2021–2025

The study considers the present scenario of the global transplant diagnostics market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.

Key Vendors

  • Thermo Fisher Scientific
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Hoffmann-La Roche
  • bioMérieux
  • Bio-Rad Laboratories
  • QIAGEN
  • Immucor

 Other Vendors

  • BAG Diagnostics
    • Business Overview
    • Major Product Offerings
  • CareDx
  • ELITechGroup
  • Genome Diagnostics
  • Illumina
  • NanoString Technologies
  • Omixon
  • Transplant Genomics
  • Wakunaga Pharmaceutical

 Market Segmentation by Product  

  • Instruments & Software
  • Consumables & Test Kits

Market Segmentation by End-user   

  • Standards Reference Laboratories
  • Hospitals and Transplant Centers
  • Research and Academic Centers

Market Segmentation by Transplant Type  

  • Solid Organs
  • Soft Tissues

Market Segmentation by Technology    

  • Molecular
  • Non-molecular

Market Segmentation by Application

  • Diagnostic
  • Research

Market Segmentation by Geography

  • Europe
    • Spain
    • France
    • Germany
    • UK
    • Italy
  • North America
    • Canada
    • US
  • APAC
    • China
    • Japan
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • Iran
    • South Africa
    • Israel

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of the study

4.4 Market Segments

4.4.1 Market Segmentation by Products

4.4.2 Market Segmentation by Applications

4.4.3 Market Segmentation by Technology

4.4.4 Market Segmentation by Transplantation

4.4.5 Market Segmentation by End-users

4.4.6 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Transplant Diagnostics: Overview

7.1.1 Background

7.1.2 Role of Diagnostics in Transplantations

8 Market Dynamics

8.1 Market Growth Enablers

8.1.1 Increasing Number of Transplantations & Prevalence of Chronic Diseases

8.1.2 Rising Incidence of Infections Caused by Transplantations

8.1.3 Increasing Shift from Serological to Molecular Diagnostic Testing in Transplant Patients

8.1.4 Technological Advancements in Transplant Diagnostics

8.2 Market Growth Restraints

8.2.1 Increasing Gap Between Number of Organ Donors & Recipients

8.2.2 Ethical Challenges Related to Organ Procurement and Transplantation

8.2.3 High Costs Associated with Transplant Diagnostics

8.3 Market Opportunities and Trends

8.3.1 Emergence of cfDNA in Transplant Diagnostics

8.3.2 Growing Demand in Emerging Economies

8.3.3 Increasing Focus on Identifying Novel Biomarkers for Minimizing Transplantation Rejection

9 Global Transplant Diagnostics Market

9.1 Market Overview

9.2 Market Size & Forecast

9.3 Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 Transplant Diagnostics Market by Products

10.1 Market Snapshot & Growth Engine

10.2 Market Overview

10.3 Consumables & Test Kits

10.3.1 Market Overview

10.3.2 Market Size & Forecast

10.4 Instruments & Software

10.4.1 Market Overview

10.4.2 Market Size & Forecast

11 Transplant Diagnostics Market by Applications

11.1 Market Snapshot & Growth Engine

11.2 Market Overview

11.3 Diagnostic Applications

11.3.1 Market Overview

11.3.2 Market Size & Forecast

11.4 Research Applications

11.4.1 Market Overview

11.4.2 Market Size & Forecast

12 Transplant Diagnostics Market by Technology

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Molecular Tests

12.3.1 Market Overview

12.3.2 Market Size & Forecast

12.4 Non-molecular

12.4.1 Market Overview

12.4.2 Market Size & Forecast

13 Transplant Diagnostics Market by Transplantation

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Solid Organ Transplantation

13.3.1 Market Overview

13.3.2 Market Size & Forecast

13.4 Soft Tissue Transplantation

13.4.1 Market Overview

13.4.2 Market Size & Forecast

14 Transplant Diagnostics Market by End-Users

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Standard Reference Laboratories

14.3.1 Market Overview

14.3.2 Market Size & Forecast

14.4 Hospitals & Transplant Centers

14.4.1 Market Overview

14.4.2 Market Size & Forecast

14.5 Academic Institutes & Research Laboratories

14.5.1 Market Overview

14.5.2 Market Size & Forecast

15 Transplant Diagnostics Market by Geography

15.1 Market Snapshot & Growth Engine

15.2 Overview

16 North America

16.1 Market Overview

16.2 Market Size & Forecast

16.3 Key Countries

16.3.1 US: Transplant Diagnostics Market Size & Forecast

16.3.2 Canada: Market Size & Forecast

17 Europe

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Key Countries

17.3.1 France: Transplant Diagnostics Market Size & Forecast

17.3.2 UK: Market Size & Forecast

17.3.3 Spain: Market Size & Forecast

17.3.4 Germany: Market Size & Forecast

17.3.5 Italy: Market Size & Forecast

18 APAC

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Key Countries

18.3.1 China: Transplant Diagnostics Market Size & Forecast

18.3.2 Japan: Market Size & Forecast

18.3.3 India: Market Size & Forecast

18.3.4 South Korea: Market Size & Forecast

18.3.5 Australia: Market Size & Forecast

19 Latin America

19.1 Market Overview

19.2 Market Size & Forecast

19.3 Key Countries

19.3.1 Brazil: Transplant Diagnostics Market Size & Forecast

19.3.2 Mexico: Market Size & Forecast

19.3.3 Argentina: Market Size & Forecast

20 Middle East & Africa

20.1 Market Overview

20.2 Key Countries

20.2.1 Saudi Arabia: Transplant Diagnostics Market Size & Forecast

20.2.2 Iran: Market Size & Forecast

20.2.3 South Africa: Market Size & Forecast

21 Competitive Landscape

21.1 Competition Overview

21.2 Market Share Analysis

21.2.1 Thermo Fisher Scientific

21.2.2 F. Hoffmann-La Roche

21.2.3 bioMérieux

21.2.4 Bio-Rad Laboratories

21.2.5 QIAGEN

21.2.6 Immucor

22 Key Company Profiles

22.1 Thermo Fisher Scientific

22.1.1 Business Overview

22.1.2 Major Product Offerings

22.1.3 Key Strengths

22.1.4 Key Strategies

22.1.5 Key Opportunities

22.2 F. Hoffmann-La Roche

22.2.1 Business Overview

22.2.2 Major Product Offerings

22.2.3 Key Strengths

22.2.4 Key Strategies

22.2.5 Key Opportunities

22.3 bioMérieux

22.3.1 Business Overview

22.3.2 Major Product Offerings

22.3.3 Key Strengths

22.3.4 Key Strategies

22.3.5 Key Opportunities

22.4 Bio-Rad Laboratories

22.4.1 Business Overview

22.4.2 Major Product Offerings

22.4.3 Key Strengths

22.4.4 Key Strategies

22.4.5 Key Opportunities

22.5 QIAGEN

22.5.1 Business Overview

22.5.2 Major Product Offerings

22.5.3 Key Strengths

22.5.4 Key Strategies

22.5.5 Key Opportunities

22.6 Immucor

22.6.1 Business Overview

22.6.2 Major Product Offerings

22.6.3 Key Strengths

22.6.4 Key Strategies

22.6.5 Key Opportunities

23 Other Prominent Vendors

23.1 BAG Diagnostics

23.1.1 Business Overview

23.1.2 Major Product Offerings

23.2 CareDx

23.2.1 Business Overview

23.2.2 Major Product Offerings

23.2.3 Key Strengths

23.2.4 Key Strategies

23.2.5 Key Opportunities

23.3 ELITechGroup

23.3.1 Business Overview

23.3.2 Major Product Offerings

23.3.3 Key Strengths

23.3.4 Key Strategies

23.3.5 Key Opportunities

23.4 Genome Diagnostics

23.4.1 Business Overview

23.4.2 Major Product Offerings

23.4.3 Key Strengths

23.4.4 Key Strategies

23.4.5 Key Opportunities

23.5 Illumina

23.5.1 Business Overview

23.5.2 Major Product Offerings

23.5.3 Key Strengths

23.5.4 Key Strategies

23.5.5 Key Opportunities

23.6 NanoString Technologies

23.6.1 Business Overview

23.6.2 Major Product Offerings

23.6.3 Key Strengths

23.6.4 Key Strategies

23.6.5 Key Opportunities

23.7 Omixon

23.7.1 Business Overview

23.7.2 Major Product Offerings

23.7.3 Key Strengths

23.7.4 Key Strategies

23.7.5 Key Opportunities

23.8 Transplant Genomics

23.8.1 Business Overview

23.8.2 Major Product Offerings

23.8.3 Key Strengths

23.8.4 Key Strategies

23.8.5 Key Opportunities

23.9 Wakunaga Pharmaceutical

23.9.1 Business Overview

23.9.2 Major Product Offerings

23.9.3 Key Strengths

23.9.4 Key Strategies

23.9.5 Key Opportunities

24 REPORT SUMMARY

24.1 Key Takeaways

24.2 Strategic Recommendations

24.3 Quantitative Summary

24.3.1 By Products

24.3.2 By Applications

24.3.3 By Transplantation

24.3.4 By Technology

24.3.5 By End-users

24.3.6 By Geography

25 Appendix

25.1 Abbreviations

List of Exhibits

Exhibit 1               Segmentation of Global Transplant Diagnostics Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               Impact of Increasing Number of Transplantations & Prevalence of Chronic Diseases

Exhibit 4               Percentage Share of Chronic Conditions in Various Countries

Exhibit 5               Impact of Rising Incidence of Infections Caused by Transplantations

Exhibit 7               Impact of Increasing Shift from Serological to Molecular Diagnostic Testing in Transplant Patients

Exhibit 8               Technological Advancements in Transplant Diagnostics

Exhibit 9               Impact of Increasing Gap Between Number of Organ Donors & Recipients

Exhibit 10             Average Waiting Time for Transplantation Recipients in US 2017 (days)

Exhibit 11             Total Number of Actual Deceased Organ Donors 2013−2018

Exhibit 12             Total Number of Utilized Deceased Organ Donors 2013−2018

Exhibit 13             Gap between Actual and Utilized Deceased Organ Donors 2013−2018

Exhibit 14             Impact of Ethical Challenges Related to Organ Procurement and Transplantation

Exhibit 15             Number of Organ Transplantations in Germany 2013-2017

Exhibit 16             Number of Organ Transplantations in Japan 2014-2017

Exhibit 17             Number of Organ Transplantations in South Africa 2013-2017

Exhibit 18             Impact of High Costs Associated with Transplant Diagnostics

Exhibit 19             Monthly Laboratory Costs Post-transplantation for In-patient Care

Exhibit 20             Monthly Laboratory Costs Post-transplantation for Out-patient Care

Exhibit 21             Impact of Emergence of cfDNA as a Non-invasive Biomarker in Transplant Diagnostics

Exhibit 22             Impact of Growing demand for Transplant Diagnostics in Emerging Economies

Exhibit 23             Incremental Growth of Transplant Diagnostics Market in China

Exhibit 24             Incremental Growth of Transplant Diagnostics Market in India

Exhibit 25             Impact of Increasing Focus on Identifying Novel Biomarkers for Minimizing Transplantation Rejection

Exhibit 26             Global Transplant Diagnostics Market 2019−2025 ($ million)

Exhibit 27             Global Transplant Diagnostics Market by Geography 2019 & 2025 (%)

Exhibit 28             Global Transplant Diagnostics Market by Products 2019 & 2025 (%)

Exhibit 29             Global Transplant Diagnostics Market by Applications 2019 & 2025 (%)

Exhibit 30             Global Transplant Diagnostics Market by Transplantation 2019 & 2025 (%)

Exhibit 31             Global Transplant Diagnostics Market by End-users 2019 & 2025 (%)

Exhibit 32             Global Transplant Diagnostics Market by Technology 2019 & 2025 (%)

Exhibit 33             Five Force Analysis 2019

Exhibit 34             Incremental Growth by Products 2019−2025

Exhibit 35             Global Transplant Diagnostics Market by Products

Exhibit 36             Global Market by Products: Incremental Growth

Exhibit 37             Global Market by Products: Absolute Growth

Exhibit 38             Global Market by Products 2019−2025 ($ million)

Exhibit 39             Global Market by Products 2019−2025 (%)

Exhibit 40             Global Consumables & Test Kits Market: Absolute & Incremental Growth

Exhibit 41             Global Reagents & Consumables Market 2019−2025 ($ million)

Exhibit 42             Global Leukemia Incidence Rate in 2018

Exhibit 43             Global Instruments & Software Market 2019−2025 ($ million)

Exhibit 44             Incremental Growth by Applications 2019-2025

Exhibit 45             Global Transplant Diagnostics Market by Applications

Exhibit 46             Global Market Overview by Applications: Snapshot

Exhibit 47             Global Market by Applications: Incremental Growth

Exhibit 48             Global Market by Applications: Absolute Growth

Exhibit 49             Global Market by Applications 2019−2025 ($ million)

Exhibit 50             Global Market by Applications 2019−2025 (%)

Exhibit 51             Global Market by Diagnostics Applications: Absolute & Incremental Growth

Exhibit 52             Global Market by Diagnostics Applications 2019−2025 ($ million)

Exhibit 53             Global Market by Research Applications: Absolute & Incremental Growth

Exhibit 54             Global Market by Research Applications 2019−2025 ($ million)

Exhibit 55             Incremental Growth by Technology 2019-2025

Exhibit 56             Global Transplant Diagnostics Market by Technology

Exhibit 57             Global Market Segmentation by Technology: Snapshot

Exhibit 58             Global Market by Technology: Incremental Growth

Exhibit 59             Global Market by Technology: Absolute Growth

Exhibit 60             Global Market by Technology 2019−2025 ($ million)

Exhibit 61             Global Market by Technology 2019−2025 (%)

Exhibit 62             Popular PCR-Based Molecular Products Offered by Market Players

Exhibit 63             Popular NGS Products Offered by Few Market Players

Exhibit 64             Global Molecular Transplant Diagnostics Market 2019−2025 ($ million)

Exhibit 65             Global Non-molecular Transplant Diagnostics Market 2019−2025 ($ million)

Exhibit 66             Incremental Growth by Transplantation 2019-2025

Exhibit 67             Global Transplant Diagnostics Market by Transplantation

Exhibit 68             Global Market Segmentation by Transplantation: Snapshot

Exhibit 69             Global Market by Transplantation: Incremental Growth

Exhibit 70             Global Market by Transplantation: Absolute Growth

Exhibit 71             Global Market by Transplantation 2019−2025 ($ million)

Exhibit 72             Global Market by Transplantation 2019−2025 (%)

Exhibit 73             Worldwide Total Kidney Transplantations 2013−2018

Exhibit 74             Worldwide Total Liver Transplantations 2013−2018

Exhibit 75             Worldwide Total Heart Transplantations 2013−2018

Exhibit 76             Worldwide Total Lung Transplantations 2013−2018

Exhibit 77             Global Solid Organ Transplant Diagnostics Market 2019−2025 ($ million)

Exhibit 78             Global Leukemia Incidence in 2018

Exhibit 79             Global Hodgkin Lymphoma Incidence in 2018

Exhibit 80             Global Non-Hodgkin Lymphoma Incidence in 2018

Exhibit 81             Global Soft Tissue Transplant Diagnostics Market 2019−2025 ($ million)

Exhibit 82             Incremental Growth by End-users 2019-2025

Exhibit 83             Global Transplant Diagnostics Market by End-users

Exhibit 84             Global Market by End-users: Incremental Growth

Exhibit 85             Global Market by End-users: Absolute Growth

Exhibit 86             Global Market by End-users 2019−2025 ($ million)

Exhibit 87             Global Market by End-users 2019−2025 (%)

Exhibit 88             Global Market by Standard Reference Laboratories: Absolute & Incremental Growth

Exhibit 89             Global Standard Reference Laboratories Market 2019−2025 ($ million)

Exhibit 90             Global Market by Hospitals & Transplant Centers: Absolute & Incremental Growth

Exhibit 91             Global Hospitals & Transplant Centers Market 2019−2025 ($ million)

Exhibit 92             Market by Academic Institutes & Research Laboratories: Absolute & Incremental Growth

Exhibit 93             Global Academic Institutes & Research Laboratories Market 2019−2025 ($ million)

Exhibit 94             Incremental Growth by Geography 2019-2025

Exhibit 95             Global Transplant Diagnostics Market by Geography

Exhibit 96             Global Market Share by Top Countries 2019

Exhibit 97             Global Market by Geography: Key Countries 2019

Exhibit 98             Global Market by Geography: Absolute Growth

Exhibit 99             Global Market by Geography: Incremental Growth

Exhibit 100          Market in North America 2019

Exhibit 101          North America Market: Absolute & Incremental Growth

Exhibit 102          North America Market 2019−2025 ($ million)

Exhibit 103          Incremental Growth in North America 2019−2025

Exhibit 104          Total Solid Organ Transplantations in the US 2013−2018

Exhibit 105          Tissue Transplantations in the US 2013-2017

Exhibit 106          Market in the US 2019−2025 ($ million)

Exhibit 107          Total Solid Organ Transplantations in Canada 2013−2018

Exhibit 108          Market in Canada 2019−2025

Exhibit 109          Europe Market 2019

Exhibit 110          Europe Market: Absolute & Incremental Growth

Exhibit 111          Incidence of Blood-related Cancers in 2018

Exhibit 112          Market in Europe 2019–2025 ($ million)

Exhibit 113          Incremental Growth in Europe 2019-2025

Exhibit 114          Total Solid Organ Transplantations in France 2013−2018

Exhibit 115          Market in France 2019–2025 ($ million)

Exhibit 116          Total Solid Organ Transplantations in the UK 2013−2018

Exhibit 117          Market in the UK 2019–2025 ($ million)

Exhibit 118          Total Solid Organ transplantations in Spain 2013−2018

Exhibit 119          Market in Spain 2019–2025 ($ million)

Exhibit 120          Total Solid Organ Transplantations in Germany 2013−2018

Exhibit 121          Market in Germany 2019–2025 ($ million)

Exhibit 122          Incidences of Total Blood-related Cancer Cases in Italy 2018

Exhibit 123          Total Solid Organ Transplantations in Italy 2013−2018

Exhibit 124          Market in Italy 2019–2025 ($ million)

Exhibit 125          Total Solid Organ Transplantations in APAC 2013−2018

Exhibit 126          APAC Market 2019

Exhibit 127          APAC Market: Absolute & Incremental Growth

Exhibit 128          Market in APAC 2019−2025 ($ million)

Exhibit 129          Incremental Growth in APAC 2019-2025

Exhibit 130          Total Solid Organ Transplantations in China 2013−2017

Exhibit 131          Total New Blood Cancer Cases in China 2018

Exhibit 132          Market in China 2019–2025 ($ million)

Exhibit 133          Total Solid Organ Transplantations in Japan 2013−2017

Exhibit 134          Annual Number of Bone Marrow Transplant Recipients by Transplant Type in Japan 2013-2017

Exhibit 135          Market in Japan 2019–2025 ($ million)

Exhibit 136          Total Solid Organ transplantations in India 2013−2018

Exhibit 137          Market in India 2019–2025 ($ million)

Exhibit 138          Total Solid Organ Transplantations in South Korea 2013−2018

Exhibit 139          Market in South Korea 2019–2025 ($ million)

Exhibit 140          Total New Blood Cancer Cases in Australia 2018

Exhibit 141          Total Solid Organ Transplantations in Australia 2013−2018

Exhibit 142          Market in Australia 2019–2025 ($ million)

Exhibit 143          Market in Latin America by Key Countries 2019

Exhibit 144          Market in Latin America: Absolute & Incremental Growth

Exhibit 145          Latin America Market 2019−2025 ($ million)

Exhibit 146          Incremental Growth in Latin America 2019-2025

Exhibit 147          Total Solid Organ Transplantations in Brazil 2013−2018

Exhibit 148          New Blood Related Cancer Incidences in Brazil 2018

Exhibit 149          Market in Brazil 2019–2025 ($ million)

Exhibit 150          Total Solid Organ Transplantations in Mexico 2013−2018

Exhibit 151          Market in Mexico 2019–2025 ($ million)

Exhibit 152          Total Solid Organ Transplantations in Argentina 2013−2018

Exhibit 153          Market in Argentina 2019–2025 ($ million)

Exhibit 154          MEA Market 2019

Exhibit 155          MEA Market: Absolute & Incremental Growth

Exhibit 156          Market in MEA 2019–2025 ($ million)

Exhibit 157          Incremental Growth in MEA 2019-2025

Exhibit 158          Total Solid Organ Transplantations in Saudi Arabia 2013−2018

Exhibit 159          Market in Saudi Arabia 2019–2025 ($ million)

Exhibit 160          Market in Iran 2019–2025 ($ million)

Exhibit 161          Total Solid Organ Transplantations in Iran 2013−2016

Exhibit 162          Total Solid Organ Transplantations in South Africa 2013−2017

Exhibit 163          Market in South Africa 2019–2025 ($ million)

Exhibit 164          Global Transplant Diagnostics Market: Vendors Share 2019

Exhibit 165          Thermo Fisher Scientific: R&D Expenditure 2016−2018 ($ million)

Exhibit 166          Thermo Fisher Scientific: Revenue by Business Segments 2017−2018 ($ million)

Exhibit 167          Thermo Fisher Scientific: Revenue by Regions 2017−2018

Exhibit 168          F. Hoffmann-La Roche: R&D Expenditure in 2016−2018 ($ billion)

Exhibit 169          F. Hoffmann-La Roche: Revenue by Business Segments in 2017−2018 ($ billion)

Exhibit 170          F. Hoffmann-La Roche: Revenue by Geography ($ billion)

Exhibit 171          bioMérieux: R&D Expenditure 2016−2018 ($ million)

Exhibit 172          bioMérieux: Revenue by Applications 2017−2018 ($ million)

Exhibit 173          bioMérieux: Revenue by Geography 2018

Exhibit 174          Bio-Rad Laboratories: Revenue by Segments 2017 & 2018 ($ million)

Exhibit 175          Bio-Rad Laboratories: Revenue by Geography 2018

Exhibit 176          QIAGEN: R&D Expenditure in 2016−2018 ($ million)

Exhibit 177          QIAGEN: Revenue by Business Segments in 2017−2018

Exhibit 178          QIAGEN: Revenue by Geography in 2018

               

Tables  

Table 1  Key Caveats

Table 2  Currency Conversion 2014−2019

Table 3  Comparison of Serological and Molecular Assays

Table 4  Capital Costs for the Implementation of Next-generation Sequencing

Table 5  Absolute Growth of Transplant Diagnostics in Developed and Emerging Economies (%)

Table 6  List of Consumables & Test Kits from Various Players

Table 7  List of Transplant Diagnostic Instruments & Software from Various Players

Table 8  List of Products Available for Diagnostic Applications of Pre- and Post-transplantations

Table 9  Healthcare Expenditure as Percent of GDP in Major Latin American Countries

Table 10               Global Transplant Diagnostics Market: Top Vendors Ranking

Table 11               Thermo Fisher Scientific: Key Product Offerings

Table 12               F. Hoffmann-La Roche: Key Product Offerings

Table 13               bioMérieux: Key Product Offerings

Table 14               Bio-Rad Laboratories: Key Product Offerings

Table 15               QIAGEN: Key Product Offerings

Table 16               Immucor: Key Product Offerings

Table 17               BAG Diagnostics: Key Product Offerings

Table 18               CareDx: Key Product Offerings

Table 19               ELITechGroup: Key Product Offerings

Table 20               Genome Diagnostics: Key Product Offerings

Table 21               Illumina: Key Product Offerings

Table 22               NanoString Technologies: Key Product Offerings

Table 23               Omixon: Key Product Offerings

Table 24               Transplant Genomics: Key Product Offerings

Table 25               Wakunaga Pharmaceutical: Key Product Offerings

Table 26               Global Transplant Diagnostics Market by Products ($ million)

Table 27               Global Market by Products (%)

Table 28               Global Market by Applications ($ million)

Table 29               Global Market by Applications (%)

Table 30               Global Market by Transplantation ($ million)

Table 31               Global Market by Transplantation (%)

Table 32               Global Market by Technology ($ million)

Table 33               Global Market by Technology (%)

Table 34               Global Market by End-users ($ million)

Table 35               Global Market by End-users (%)

Table 36               Global Market by Geography ($ million)

Table 37               Global Market by Geography (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date